PubMed · 2014 · 18 citations · 17 references
MedicineHematologyInternal MedicineEpidemiologyMedical GeneticsRisk AssessmentCoagulation AbnormalitiesDeep Vein ThrombosisGenetic RiskThrombosisThrombotic DisordersVenous DiseaseControl Group DesignMatched Control GroupMedian AgePadua ScoreRisk Prediction ScoresThrombosis Risk StratificationThrombotic Risk AssessmentThrombotic Risk Stratification
AIM: This study investigates the accuracy of two scores in predicting the risk of acute lower extremity deep vein thrombosis. PATIENTS AND METHODS: The study included 170 patients [85 (50%) women and 85 (50%) men] who were diagnosed with acute lower extremity deep vein thrombosis (DVT) with duplex ultrasonography. Median age was 62 (52.75; 72) years. The control group consisted of 166 subjects [96 (57.8%) women and 70 (42.2%) men], without DVT, matched for age (± one year) to those in the group with DVT. The patients and controls were selected from those admitted to the internal medicine, cardiology and geriatrics wards within the Municipal Hospital of Cluj-Napoca, Romania, between October 2009 and June 2011. Clinical, demographic and lab data were recorded for each patient. For each patient we calculated the prior risk of DVT using two prediction scores: Caprini and Padua. RESULTS: According to the Padua score only 93 (54.7%) patients with DVT had been at high risk of developing DVT, while 48 (28.9%) of controls were at high risk of developing DVT. When Padua score included PAI-1 4G/5G and MTHFR C677T polymorphisms, the sensitivity increased at 71.7%. Using the Caprini score, we determined that 147 (86.4%) patients with DVT had been at high risk of developing DVT, while 103 (62%) controls were at high risk of developing DVT. A Caprini score higher than 5 was the strongest predictor of acute lower extremity DVT risk. CONCLUSIONS: The Caprini prediction score was more sensitive than the Padua score in assessing the high risk of DVT in medical patients. PAI-1 4G/5G and MTHFR C677T polymorphisms increased the sensitivity of Padua score.
17
Antithrombotic Therapy for VTE Disease
Clive Kearon, Elie A. Akl, Anthony J. Comerota et al. · CHEST Journal · 2012 · 6.1K citations · Full text
Mutation in blood coagulation factor V associated with resistance to activated protein C
Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al. · Nature · 1994 · 3.8K citations
Medicine, Genetics, Hematology +14
Prevention of Venous Thromboembolism
William Geerts, John A. Heit, Charles Marc Samama · CHEST Journal · 2008 · 3.8K citations
Sofia Barbar, Franco Noventa, Valeria Rossetto et al. · Journal of Thrombosis and Haemostasis · 2010 · 1.2K citations · Full text
Michele G. Beckman, W. Craig Hooper, Sara E. Critchley et al. · American Journal of Preventive Medicine · 2010 · 1.1K citations
Pharmacy, Health Services Administration, Preventive Medicine +15